Author

Moreno Moreno-Aspitia

Institution: Mayo Clinic in Florida

Observed institution: Mayo Clinic in Florida

OpenAlex ID: A5077469742

Abstract PS6-03: Prognostic value of clinical treatment score post-5 years (CTS5) and late relapse risk in hormone receptor-positive HER2-positive breast cancer in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) and NSABP B-31 (NRG) trials

2021 · Tanyami Pai, Angelica Gil, et al. · Cancer Research · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: